Simultaneous population pharmacokinetic modelling of darunavir and ritonavir Once daily in HIV-infected patients: evaluation of lower ritonavir dose

被引：0
|
作者：
Dickinson, L. [1 ]
Jackson, A. [2 ]
Garvey, L. [3 ]
Watson, V [1 ]
Khoo, S. [1 ]
Winston, A. [3 ]
Boffito, M. [2 ]
Davies, G. [1 ]
Back, D. [1 ]
机构：
[1] Univ Liverpool, Dept Mol & Clin Pharmacol, Pharmacol Res Labs, Liverpool L69 3BX, Merseyside, England
[2] Chelsea & Westminster Fdn Trust, St Stephens Ctr, London, England
[3] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept HIV & GU Med, London, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2012年 / 15卷
关键词：
D O I：
10.7448/IAS.15.6.18331
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [21] Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patients
    Mallolas, J
    Blanco, JL
    Sarasa, M
    Giner, V
    Martínez, E
    García-Viejo, MA
    Arnaiz, JA
    Cruceta, A
    Soy, D
    Tuset, M
    Soriano, A
    Codina, C
    Pumarola, T
    Carné, X
    Gatell, JM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (03) : 229 - 235
  • [22] Dual therapy with fixed dose combination of darunavir/ritonavir plus raltegravir in HIV-infected patients in Argentina
    Rombini, F.
    Cecchini, D. M.
    Uruena, A.
    Vecchio, C.
    Huberman, M.
    Cassetti, I.
    HIV MEDICINE, 2019, 20 : 66 - 66
  • [23] Efficacy of a Reduced Dose of Darunavir/Ritonavir in a Small Cohort of Antiretroviral-Naive HIV-Infected Patients
    Lanzafame, Massimiliano
    Lattuada, Emanuela
    Rigo, Fabio
    Vento, Sandro
    AIDS PATIENT CARE AND STDS, 2013, 27 (06) : 315 - 316
  • [24] Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients
    Sekar, Vanitha
    Lefebvre, Eric
    Marien, Kris
    De Pauw, Martine
    Vangeneugden, Tony
    Pozniak, Anton
    Hoetelmans, Richard M. W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (01) : 116 - 119
  • [25] Efficacy of once-daily darunavir/ritonavir 800/100 mg in HIV-infected, treatment-experienced patients with no baseline resistance-associated mutations to darunavir
    De Meyer, Sandra M. J.
    Spinosa-Guzman, Sabrina
    Vangeneugden, Tony J.
    de Bethune, Marie-Pierre
    Miralles, G. Diego
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (02) : 179 - 182
  • [26] Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients
    Nishijima, Takeshi
    Hamada, Yohei
    Watanabe, Koji
    Komatsu, Hirokazu
    Kinai, Ei
    Tsukada, Kunihisa
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    PLOS ONE, 2013, 8 (10):
  • [27] Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapy
    Mena, Alvaro
    Cid, Purificacion
    Duenas, Carlos
    Angeles Garcinuno, Maria
    Francisco Lorenzo, Juan
    Margusino, Luis
    Quinones, Marina
    Grande, Carmen
    Rodriguez-Osorio, Iria
    Castro, Angeles
    HIV CLINICAL TRIALS, 2018, 19 (05): : 197 - 201
  • [28] Darunavir minimum plasma concentration and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patients
    Gutierrez-Valencia, Alicia
    Torres-Cornejo, Almudena
    BenMarzouk-Hidalgo, Omar J.
    Ruiz-Valderas, Rosa
    Lluch, Amparo
    Viciana, Pompeyo
    Lopez-Cortes, Luis F.
    ANTIVIRAL THERAPY, 2014, 19 (05) : 443 - 447
  • [29] Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients
    Gianotti, Nicola
    Cozzi-Lepri, Alessandro
    Antinori, Andrea
    Castagna, Antonella
    De Luca, Andrea
    Celesia, Benedetto Maurizio
    Galli, Massimo
    Mussini, Cristina
    Pinnetti, Carmela
    Spagnuolo, Vincenzo
    Monforte, Antonella d'Arminio
    Ceccherini-Silberstein, Francesca
    Andreoni, Massimo
    PLOS ONE, 2017, 12 (02):
  • [30] Pharmacokinetics of once-daily tenofovir, emtricitabine, ritonavir and fosamprenavir in HIV-infected subjects
    Parks, David A.
    Jennings, Harold C.
    Taylor, Christopher W.
    Acosta, Edward P.
    AIDS, 2007, 21 (10) : 1373 - 1375
12345